Goldman Sachs Group »

Arrowhead Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $33M 1.3M 25.99
2024-03-31 $30M 1.0M 28.60
2023-12-31 $33M 1.1M 30.60
2023-09-30 $12M 449k 26.87
2023-06-30 $23M 641k 35.66
2023-03-31 $18M 713k 25.40
2022-12-31 $30M 749k 40.56
2022-06-30 $34M 977k 35.21
2022-03-31 $36M 785k 45.99
2021-12-31 $42M 636k 66.30
2021-09-30 $47M 755k 62.43
2021-03-31 $63M 946k 66.31
2020-12-31 $87M 1.1M 76.73
2020-09-30 $39M 903k 43.06
2020-06-30 $29M 676k 43.19
2019-12-31 $56M 877k 63.43
2019-09-30 $29M 1.0M 28.18
2019-06-30 $25M 928k 26.50
2019-03-31 $23M 1.2M 18.35
2018-12-31 $16M 1.3M 12.42
2018-09-30 $4.4M 232k 19.17
2018-06-30 $1.2M 91k 13.61
2018-03-31 $3.9M 543k 7.21
2017-12-31 $637k 173k 3.68
2017-09-30 $189k 44k 4.34
2017-06-30 $513k 317k 1.62
2017-03-31 $133k 72k 1.86
2016-12-31 $339k 219k 1.55
2016-09-30 $283k 39k 7.36
2016-06-30 $174k 33k 5.33